Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Nanoscale|July 24, 2014
Au@Ag core/shell nanoparticles as colorimetric probes for cyanide sensingJing-bin Zeng, Ying-ying Cao, Jing-jing Chen, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 10, 2025
Serum High-Density Lipoprotein Cholesterol Concentrations in Pancreatic Ductal Adenocarcinoma and Its Association With Histological Grade in a Chinese PopulationYing-Ying Cao, Xiao-Jing Lv, Hui Li, et al.
Free Radical Biology & Medicine|March 21, 2006
Cap1p is involved in multiple pathways of oxidative stress response in Candida albicansYan Wang, Ying-Ying Cao, Xin-Ming Jia, et al.
Biological & Pharmaceutical Bulletin|December 2, 2008
In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazoleShan Huang, Ying Ying Cao, Bao Di Dai, et al.
Biological & Pharmaceutical Bulletin|January 5, 2007
Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 inductionHui Shen, Mao-Mao An, De Jun Wang, et al.
Clinical and Experimental Pharmacology & Physiology|May 6, 2009
Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasisYan Wang, Xin-Ming Jia, Jian-Hui Jia, et al.
Acta Biochimica Et Biophysica Sinica|July 7, 2005
cDNA array analysis of the differential expression change in virulence-related genes during the development of resistance in Candida albicansZheng Xu, Yong-Bing Cao, Jun-Dong Zhang, et al.
Biological & Pharmaceutical Bulletin|May 3, 2011
High-frequency genetic contents variations in clinical Candida albicans isolatesFeng Yang, Tian-Hua Yan, Elena Rustchenko, et al.
Biological & Pharmaceutical Bulletin|October 4, 2006
In vitro and in vivo activities of HQQ-3, a new triazole antifungal agentJing-Xia Zhao, Ying-Ying Cao, Hua Quan, et al.
Pageof 4